Richard Day is Vice President, R&D Medical Affairs & Clinical Development at ADM Health & Wellness, where he leads a global portfolio of clinical research across bioactive ingredients, with a particular emphasis on biotics. A medical doctor by training, his expertise spans digestive, immune, metabolic, healthy ageing, and mental health research across human and animal studies. He sits on the Scientific Committee of the International Probiotics Association and has authored multiple peer-reviewed publications. Richard holds degrees from the University of Oxford and King’s College London and is a Member of the Royal College of Psychiatrists.